HNN3.0
Register
Register
Register

Solgate GmbH

Company (SME)

Klosterneuburg, Austria
2 profile visits

About

Solgate is a drug discovery company focused on unlocking the therapeutic potential of solute carrier (SLC) transporters. By combining deep transporter biology with cell-native functional assays and chemistry tailored to membrane proteins, Solgate aims to identify and develop first-in-class medicines against previously inaccessible SLC targets.

Representatives

CEO

Solgate GmbH

Marketplace (1)

  • Project cooperation

    SME Innovation Partner

    Solgate is a biotech SME in drug discovery for complex diseases, supporting target validation, small molecules, and precision medicine.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    CEO at Solgate GmbH

    Klosterneuburg, Austria